Additionally, an expected label expansion by the FDA for the treatment of asymptomatic severe aortic stenosis is anticipated by mid-2025 ... particularly in transcatheter valve therapies. BofA ...
Middle-aged adults who need an aortic valve replacement fare better with mechanical devices than with the valves made from animal tissues that they currently most often receive, U.S. researchers ...
A study reveals that middle-aged adults fare better with mechanical aortic valves compared to animal tissue-based valves. The research, presented at the Society for Thoracic Surgery annual meeting, ...
Gen.2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. measuring ...